Pharmaceuticals & Biotechnology (4570)

21,726.23
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 19,184.55

Latest ShareCast News

AstraZeneca's Enhertu gets further EU approval

By Frank Prenesti

Date: Friday 04 Apr 2025

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu has been approved in the European Union as a monotherapy for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-low or HER2-ultralow breast cancer, the companies said on Friday.

London close: Stocks slide in global reaction to Trump tariffs

By Josh White

Date: Thursday 03 Apr 2025

(Sharecast News) - London stocks closed sharply lower on Thursday as global markets reacted negatively to US president Donald Trump's unexpectedly aggressive global tariff policy announced overnight.

ValiRx terminates exclusive negotiations with TheoremRx

By Josh White

Date: Thursday 03 Apr 2025

(Sharecast News) - ValiRx announced the immediate termination of its letter of intent with TheoremRx on Thursday, ending exclusive negotiations originally set to run until 31 May.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 21,726.23
Closing Price Change 350.12
% Change 1.64 %
03-Apr-25 Close 21,726.23

Top Risers

Price Change
IMM 2.95p +11.3%
SVNS 0.18p +11.1%
SAR 13.67p +3.1%
FARN 215.26p +2.5%
POLB 2.53p +2.2%
AGY 6.38p +2.0%
OPTI 14.75p +1.7%
HEMO 193.25p +1.3%
STX 2.83p +1.2%
SCLP 8.20p +0.6%

Top Fallers

Price Change
VRCI 2.11p -10.1%
VAL 0.42p -7.8%
ANP 336.67p -5.8%
TCF 0.21p -5.6%
HCM 224.00p -5.1%
N4P 0.41p -4.2%
BVXP 2,283.33p -3.7%
SBTX 24.32p -2.7%
HIK 1,907.00p -2.5%
OXB 267.00p -1.5%

Top of Page